axway.com CUSTOMER Q&A Novartis has a rich history of investing in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. As the industry faces acute disruption, the company’s prescription for ongoing success hinges on APIs and microservices. Pascal Bouquet, Global Head of Architecture for Drug Development, answers a few questions about how digital transformation is moving Novartis forward. Why did Novartis need a digital transformation? There is a huge disruption happening in healthcare. The healthcare system will be drastically different 10 years from now. We need to be able to keep innovating and finding new ways to reduce the time between discovery of a molecule and its sale as a medicine

Join for free to read